Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer
Industrial Technology
Healthcare
Software
Energy
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
INT
DA
DE
FR
SV
US
Main menu button
Team
Deals
Contact
Team
Deals
Contact
News
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Ytrade Group
Zazz Energy
Zinzino
All
01 Sep 2025
Equity research Viva Wine Group, Q2 2025: Soft markets, but expansion is underway
Equity Research
Viva Wine Group
29 Aug 2025
Equity research Zinzino Q2, 2025: Expansion costs hamper margins, but strong outlook
Equity Research
Zinzino
28 Aug 2025
Equity research Immunovia: Eventful Q2 and rights issue to support PancreaSure launch
Equity Research
Immunovia
28 Aug 2025
Equity Research Svenska Aerogel, Q2 2025: Strong growth, but lower than expected revenues
Equity Research
Svenska Aerogel
28 Aug 2025
Equity research Viva Wine Group Q2, 2025: Stable performance in a soft market
Equity Research
Viva Wine Group
27 Aug 2025
Equity research Nosa Plugs Q2, 2025: Growth ahead but mixed results in Q2
Equity Research
Nosa Plugs
25 Aug 2025
Analys Elicera Therapeutics: Låg dos tillräckligt för att eliminera aktivt lymfom i fyra av sex patienter
Equity Research
Elicera Therapeutics
21 Aug 2025
Equity research, White Pearl Technology Group: A hidden gem among the tech companies
Equity Research
White Pearl Technology Group
19 Aug 2025
Equity Research KlaraBo: The option programme demonstrates a strong commitment
Equity Research
KlaraBo
13 Aug 2025
Equity Research Svenska Aerogel: Financing secured through directed issues of units
Equity Research
Svenska Aerogel
11 Aug 2025
Equity research Viva Wine Group, Q2 2025: No market tailwind but support from Delta acquisition
Equity Research
Viva Wine Group
25 Jul 2025
Equity research, Candles Scandinavia: Unlocking shareholder value through a sizable strategic acquisition
Equity Research
Candles Scandinavia
21 Jul 2025
Equity Research ALM Equity Q2 2025: More housing starts are needed
Equity Research
ALM Equity
18 Jul 2025
Equity Research KlaraBo, Q2 2025: Focus on renovation and acquisitions
Equity Research
KlaraBo
17 Jul 2025
Equity Research KlaraBo, Q2 2025: Good momentum in the renovation of apartments
Equity Research
KlaraBo
17 Jul 2025
Equity Research ALM Equity, Q2 2025: The turnaround delayed until the end of 2025
Equity Research
ALM Equity
16 Jul 2025
Equity research CDON Q2 2025: Back to growth sooner than expected
Equity Research
CDON
15 Jul 2025
Equity research CDON Q2 2025: Back to growth
Equity Research
CDON
14 Jul 2025
Equity research Zinzino Q2 2025: Ahead of the curve
Equity Research
Zinzino
11 Jul 2025
Equity Research Nosa Plugs: Positive results and proof of concept
Equity Research
Nosa Plugs
1
2
3
4
5
…
61